US-based manufacturing company AnX Robotica has received de novo clearance from the US Food and Drug Administration (FDA) for its artificial intelligence (AI)-assisted endoscopy tool NaviCam ProScan.
NaviCam Proscan utilises a deep learning algorithm called convolutional neural networks (CNNs), which are designed to identify and differentiate healthy tissue and abnormal lesions in different images.